Core Viewpoint - Shaanxi Jinye (000812) has reported impressive financial results for 2024, showcasing strong growth in revenue and net profit, along with a significant increase in cash flow from operating activities [2]. Financial Performance - The company achieved an operating revenue of 1.44 billion yuan in 2024, representing a year-on-year growth of 16.26% [2]. - The net profit attributable to the parent company reached 42.02 million yuan, marking a year-on-year increase of 5.67% [2]. - The net cash flow from operating activities hit a record high of 302 million yuan, showing substantial growth [2]. - Cash received from sales of goods and services amounted to 1.413 billion yuan, accounting for over 98% of total revenue, indicating strong revenue quality [2]. Business Segments - Shaanxi Jinye operates in three main business categories: education, tobacco-related industries, and medical care [4]. - The education segment primarily focuses on higher education and educational investment, with its main operational entity being Xi'an Mingde Polytechnic College, which ranks among the top private colleges in Shaanxi province [4]. - The tobacco-related industry has established a strong brand and industry influence, particularly in the western region of China, with major shareholders including Shaanxi Tobacco Investment Management Co., Ltd. and Hubei China Tobacco Industrial Co., Ltd. [4][5]. - The medical care segment is in the preparatory phase for the establishment of the Handu Hospital project, with formal project initiation underway [5]. Future Outlook - The company plans to adhere strictly to national laws and regulations, as well as relevant rules from the China Securities Regulatory Commission and the Shenzhen Stock Exchange, to ensure sustainable development [6].